Related Documents
-
Notice: Meetings: Oncologic Drugs Advisory Committee
83 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— Cardiovascular and Renal Drugs Advisory Committee
88 reads -
Notice: Meetings: Blood Products Advisory Committee
57 reads -
Notice: Federal Food, Drug, and Cosmetic Act: Psychopharmacologic Drugs Advisory Committee
194 reads -
Notice: Meetings: Pediatric Advisory Committee
39 reads -
Notice: Medical devices: Psychopharmacologic Drugs Advisory Committee
88 reads -
Notice: Meetings: Peripheral and Central Nervous System Drugs Advisory Committee
37 reads -
Notice: Meetings: Medical Devices Advisory Committee
14 reads -
Notice: Human drugs:
New drug applications— Blood Products Advisory Committee
21 reads -
Notice: Meetings: Anesthetic and Life Support Drugs Advisory Committee
103 reads -
Notice: Human drugs:
New drug applications— Medical Devices Advisory Committee
54 reads -
Notice: Meetings: Pediatric Advisory Committee
70 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— Cellular, Tissue and Gene Therapies Advisory Committee
151 reads -
Notice: Meetings: Cardiovascular and Renal Drugs Advisory Committee
280 reads -
Notice: Meetings: Vaccines and Related Biological Products Advisory Committee
64 reads -
Notice: Meetings: Cardiovascular and Renal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; joint meeting
44 reads -
Notice: Meetings: Anesthetic and Life Support Drugs Advisory Committee
95 reads -
Notice: Federal Food, Drug, and Cosmetic Act: Pediatric Advisory Committee
194 reads -
Notice: Human drugs and biological products: Drug Safety and Risk Management Advisory Committee
34 reads -
Notice: Meetings: Blood Products Advisory Committee
74 reads
Related Documents
Flag this document
2 Pages
